The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Cyberonics Inc

Nasdaq: CYBX
Last

(U.S.) $59.61

Today's change0.00 0.00%
Updated June 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Cyberonics Inc

Nasdaq: CYBX
Last

(U.S.) $59.61

Today's change0.00 0.00%
Updated June 29 4:00 PM EDT. Delayed by at least 15 minutes.

Cyberonics Inc closed at (U.S.)$59.61.

Shares have lost 4.33% over the last five days, but have gained 7.06% over the last year to date. This security has underperformed the S&P 500 by 9.96% during the last year.

Key company metrics

  • Open(U.S.) $60.50
  • Previous close(U.S.) $59.61
  • High(U.S.) $60.86
  • Low(U.S.) $59.58
  • Bid / Ask-- / --
  • YTD % change+7.06%
  • Volume440,791
  • Average volume (10-day)298,862
  • Average volume (1-month)453,518
  • Average volume (3-month)347,014
  • 52-week range(U.S.) $48.19 to (U.S.) $76.48
  • Beta1.00
  • Trailing P/E27.45×
  • P/E 1 year forward23.24×
  • Forward PEG1.55×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.17
Updated June 29 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+19.84%

Based on its net profit margin of 19.84%, Cyberonics Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.15%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 24, 201504/24/2015Jan 23, 201501/23/2015Oct 24, 201410/24/2014Jul 25, 201407/25/2014
Revenue74727372
Total other revenue--------
Total revenue74727372
Gross profit66666766
Total cost of revenue8776
Total operating expense57484750
Selling / general / administrative30313033
Research & development11111111
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)90--0
Other operating expenses, total--------
Operating income17242622
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax17242622
Income after tax11171714
Income tax, total6799
Net income11171714
Total adjustments to net income--------
Net income before extra. items11171714
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items11171714
Inc. avail. to common incl. extra. items11171714
Diluted net income11171714
Dilution adjustment--------
Diluted weighted average shares26262727
Diluted EPS excluding extraordinary itemsvalue per share0.400.620.640.50
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.610.620.640.50